GLOW Blend 80mg
$145.00
- Description
- SIDE EFFECTS
- DOSAGES
Description
Novum BioScience GLOW Blend 80mg
Glow is a specialized peptide formulation designed to enhance skin health, radiance, and overall appearance through a multi-faceted approach to cellular rejuvenation. This proprietary blend combines three powerful peptides that work synergistically: GHK-Cu (Copper Tripeptide-1), BPC-157 (Body Protection Compound-157), and TB-500 (Thymosin Beta-4).
The formulation works through complementary mechanisms: GHK-Cu stimulates collagen and elastin production while acting as a powerful antioxidant; BPC-157 accelerates tissue repair and reduces inflammation; and TB-500 promotes cell migration and systemic regeneration. Together, these compounds create a comprehensive approach to skin rejuvenation that addresses multiple aspects of aging and damage simultaneously.
Research suggests this peptide combination provides benefits including reduced fine lines and wrinkles, improved skin firmness and elasticity, accelerated wound healing, enhanced skin clarity and tone, and overall anti-aging effects. The systemic action of these peptides allows for comprehensive skin benefits that work from within the body to support skin health at the foundational level, creating results that may be difficult to achieve with surface treatments alone.
Common side effects are mild and transient, primarily driven by the copper component (GHK-Cu):
Injection Site Reactions: Redness, minor swelling, or itching at the injection site, typically resolving within 2–6 hours.
Copper-Related Sensations: A brief 30–60 second sting upon injection, mild facial flushing/warmth (vasodilation), or a temporary metallic taste.
GI and Systemic Effects: Occasional mild nausea (often from BPC-157, especially on an empty stomach) and mild fatigue or drowsiness during the first few days of a new cycle.
Rare or unrelated effects include temporary skin “purging” (accelerated cell turnover), mild headaches, or light nausea. Serious adverse events are rare at standard doses, though copper toxicity is not a concern for healthy individuals but should be avoided by those with Wilson’s disease.
The standard skincare dosage protocol uses GHK-Cu as the anchor, targeting 2mg per dose.
To achieve this, reconstitute the 80mg vial with 2.5mL of bacteriostatic water. Each daily subcutaneous injection should draw 0.1mL (10 units on a U-100 insulin syringe), which delivers 2mg GHK-Cu along with 400mcg of BPC-157 and 400mcg of TB-500/TB-4.
Protocol Details:
Frequency: Daily for weeks 1–4, then 5 times per week for weeks 5–8, followed by 2–3 times per week for maintenance.
Cycle Length: Typically 8–12 weeks active use, followed by a 4–8 week break.
Note: If a vial contains KPV (an anti-inflammatory peptide), it is often labeled KLOW (50/10/10/10 ratio) rather than GLOW; the dosage math remains identical for the shared components.
